14 1

Full metadata record

DC FieldValueLanguage
dc.contributor.author최보율-
dc.date.accessioned2019-12-03T03:35:25Z-
dc.date.available2019-12-03T03:35:25Z-
dc.date.issued2017-12-
dc.identifier.citationINFECTION AND CHEMOTHERAPY, v. 49, no. 4, page. 268-274en_US
dc.identifier.issn2093-2340-
dc.identifier.issn2092-6448-
dc.identifier.urihttps://icjournal.org/DOIx.php?id=10.3947/ic.2017.49.4.268-
dc.identifier.urihttp://repository.hanyang.ac.kr/handle/20.500.11754/116729-
dc.description.abstractBackground: Despite declines in mortality and morbidity rates of patients with human immunodeficiency virus (HIV) infection as the result of highly active antiretroviral therapy, liver diseases due to chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are a leading cause of death among HIV-infected patients. However, HIV and HBV or HCV coinfection is still poorly documented, and more information is needed to better understand the characteristics of HIV-infected patients in Korea. Materials and Methods: A cross-sectional study was performed to investigate clinical characteristics and prevalence of HBV and HCV infection in HIV patients enrolled in the Korea HIV/acquired immune deficiency syndrome (AIDS) cohort study from 17 institutions between December 2006 and July 2013. Results: Among the 1,218 HIV-infected participants, 541 were included in this study. The prevalence of HBV-HIV and HCV-HIV coinfection was 5.0% (27/541) and 1.7% (9/541), respectively. There was no patient who was positive for both HBs antigen and HCV antibody. In multivariate logistic regression analysis, HBV unvaccinated status was a significant risk factor for HBV-HIV coinfection (odds ratio = 4.95, 95% confidence interval = 1.43-17.13). Conclusion: HBV and HCV infection was more common in HIV-infected persons enrolled in the Korean HIV/AIDS cohort, than in the general population in Korea.en_US
dc.description.sponsorshipThis work was supported by a fund of the Chronic Infectious Disease Cohort Study [Grant number 4800-4859-304, 2016E51003-00] by Research of Korea Centers for Disease Control and Prevention.en_US
dc.language.isoen_USen_US
dc.publisherKOREAN SOC CHEMOTHERAPYen_US
dc.subjectHIV infectionen_US
dc.subjectHepatitis B virusen_US
dc.subjectHepatitis C virusen_US
dc.subjectCoinfectionen_US
dc.titleHuman immunodeficiency virus (HIV) and hepatitis virus coinfection among HIV-infected Korean patients: The Korea HIV/AIDS cohort studyen_US
dc.typeArticleen_US
dc.relation.no4-
dc.relation.volume49-
dc.identifier.doi10.3947/ic.2017.49.4.268-
dc.relation.page268-274-
dc.relation.journalInfection and Chemotherapy-
dc.contributor.googleauthorKim, Yong Chan-
dc.contributor.googleauthorAhn, Jin Young-
dc.contributor.googleauthorKim, June Myung-
dc.contributor.googleauthorKim, Youn Jeong-
dc.contributor.googleauthorPark, Dae Won-
dc.contributor.googleauthorYoon, Young Kyung-
dc.contributor.googleauthorSong, Joon Young-
dc.contributor.googleauthorKim, Shin Woo-
dc.contributor.googleauthorLee, Jin Soo-
dc.contributor.googleauthorChoi, Bo Youl-
dc.relation.code2017028876-
dc.sector.campusS-
dc.sector.daehakCOLLEGE OF MEDICINE[S]-
dc.sector.departmentDEPARTMENT OF MEDICINE-
dc.identifier.pidbychoi-


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE